![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Theysohn, Jens M.; Demircioglu, Aydin; Kleditzsch, Malte; Ludwig, Johannes M.; Weber, Manuel; Umutlu, Lale; Li, Yan; Kircher, Malte; Lapa, Constantin; Buck, Andreas; Koehler, Michael; Wildgruber, Moritz; Lange, Christian M.; Palard, Xavier; Garin, Etienne; Herrmann, Ken; Forsting, Michael und Nensa, Felix
(2022):
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation.
In: Scientific Reports, Bd. 12, Nr. 1, 20718
Löhr, Mario; Härtig, Wolfgang; Schulze, Almut; Kroiss, Matthias; Sbiera, Silviu; Lapa, Constantin; Mages, Bianca; Strobel, Sabrina; Hundt, Jennifer Elisabeth; Bohnert, Simone; Kircher, Stefan; Janaki-Raman, Sudha und Monoranu, Camelia-Maria
(2022):
SOAT1: A Suitable Target for Therapy in High-Grade Astrocytic Glioma?
In: International Journal of Molecular Sciences, Bd. 23, Nr. 7, 3726
Koehler, Viktoria Florentine; Berg, Elke; Adam, Pia; Weber, Gian-Luca; Pfestroff, Andreas; Luster, Markus; Kutsch, Jana Maria; Lapa, Constantin; Sandner, Benjamin; Rayes, Nada; Fuss, Carmina Teresa; Kreissl, Michael; Hoster, Eva; Allelein, Stephanie; Schott, Matthias; Todica, Andrei; Fassnacht, Martin; Kroiss, Matthias und Spitzweg, Christine
(2021):
Real world efficacy and safety of multi-tyrosine kinase inhibitors in radioiodine refractory thyroid cancer.
In: Thyroid
Koehler, Viktoria Florentine; Berg, Elke; Adam, Pia; Weber, Gian-Luca; Pfestroff, Andreas; Luster, Markus; Kutsch, Jana Maria; Lapa, Constantin; Sandner, Benjamin; Rayes, Nada; Fuss, Carmina Teresa; Kreissl, Michael C.; Hoster, Eva; Allelein, Stephanie; Schott, Matthias; Todica, Andrei; Fassnacht, Martin; Kroiss, Matthias und Spitzweg, Christine
(2021):
Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid Cancer.
In: Thyroid, Bd. 31, Nr. 10: S. 1531-1541
Lapa, Constantin; Nestle, Ursula; Albert, Nathalie L.; Baues, Christian; Beer, Ambros; Buck, Andreas; Budach, Volker; Butof, Rebecca; Combs, Stephanie E.; Derlin, Thorsten; Eiber, Matthias; Fendler, Wolfgang P.; Furth, Christian; Gani, Cihan; Gkika, Eleni; Grosu, Anca-L; Henkenberens, Christoph; Ilhan, Harun; Lock, Steffen; Marnitz-Schulze, Simone; Miederer, Matthias; Mix, Michael; Nicolay, Nils H.; Niyazi, Maximilian; Pottgen, Christoph; Rodel, Claus M.; Schatka, Imke; Schwarzenboeck, Sarah M.; Todica, Andrei S.; Weber, Wolfgang; Wegen, Simone; Wiegel, Thomas; Zamboglou, Constantinos; Zips, Daniel; Zophel, Klaus; Zschaeck, Sebastian; Thorwarth, Daniela und Troost, Esther G. C.
(2021):
Value of PET imaging for radiation therapy.
In: Strahlentherapie und Onkologie, Bd. 197, Nr. 9: S. 757-779
Werner, Rudolf A.; Ilhan, Harun; Lehner, Sebastian; Papp, Laszlo; Zsoter, Norbert; Schatka, Imke; Muegge, Dirk O.; Javadi, Mehrbod S.; Higuchi, Takahiro; Buck, Andreas K.; Bartenstein, Peter; Bengel, Frank; Essler, Markus; Lapa, Constantin und Bundschuh, Ralph A.
(2019):
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy.
In: Molecular Imaging and Biology, Bd. 21, Nr. 3: S. 582-590
Werner, Rudolf; Ilhan, Harun; Lehner, Sebastian; Papp, Laszlo; Zsoter, Norbert; Schatka, Imke; Mügge, Dirk; Higuchi, Takahiro; Essier, Markus; Buck, Andreas; Bengel, Frank; Bartenstein, Peter; Lapa, Constantin und Bundschuh, Ralph
(2017):
Somatostatin-Receptor Based Tumor Heterogeneity Predicts Survival in Pancreatic Neuroendocrine Tumor Patients Envisaged for Endoradiotherapy.
In: Journal of Nuclear Medicine, Bd. 58
Werner, Rudolf A.; Lapa, Constantin; Ilhan, Harun; Higuchi, Takahiro; Buck, Andreas K.; Lehner, Sebastian; Bartenstein, Peter; Bengel, Frank; Schatka, Imke; Muegge, Dirk O.; Papp, László; Zsótér, Norbert; Große-Ophoff, Tobias; Essler, Markus und Bundschuh, Ralph A.
(2017):
Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity.
In: Oncotarget, Bd. 8, Nr. 4: S. 7039-7049